Is a complete NSE/QMSMEDI research report available?

No complete published report is available for nse/QMSMEDI (NSE/QMSMEDI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/QMSMEDI stock profile: metrics, valuation and analysis

Market cap	2.8B
Revenue (ttm)	1.8B
Net income (ttm)	108.6M
EPS (ttm)	₹5.46
Shares out	17.9M
P/E (trailing)	28.4x
Dividend	₹0.50 (0.32%)
Volume	66
Beta	0.67

All NSE/QMSMEDI indicators

Market & fundamental data

Available fields

193

Groups with data

Currency

INR

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	89
Employees Change	22%
Employees Change Percent	32.84
Enterprise value	INR 3.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Distribution
Isin	INE0FMW01018
Last refreshed	2026-09-09
Market cap	INR 2.8B
Price	INR 155
Price currency	INR
Rev Per Employee	20,589,662.92x
Sector	Healthcare
Sector PE	47.97
Sector PE Fwd	38.43
Sic	5047
Symbol	nse/QMSMEDI
Website	https://qmsmas.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.92%
EV Earnings	32.66x
EV/EBIT	15.3x
EV/EBITDA	12.99x
EV/FCF	25.98x
EV/Sales	1.93x
FCF yield	4.93%
P/B ratio	2.43x
P/E ratio	28.43x
P/S ratio	1.51x
PE Ratio3 Y	18.57x
PE Ratio5 Y	21.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.65%
EBITDA Margin	14.89%
FCF margin	7.9%
Gross margin	49.32%
Gross Profit	INR 903.8M
Gross Profit Growth	10.45%
Gross Profit Growth Q	49.25%
Gross Profit Growth3 Y	44.41%
Gross Profit Growth5 Y	23.37%
Net Income	INR 108.6M
Net Income Growth	-14.02%
Net Income Growth Q	24.6%
Net Income Growth Qo Q	112.05%
Net Income Growth3 Y	9.94%
Net Income Growth5 Y	-0.11%
Pretax Margin	9.55%
Profit Margin	5.92%
Profit Per Employee	INR 1.2M
Roa5y	8.49
Roe5y	18.36
ROIC	9.26
Roic5y	12.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	66.78%
Cagr3y	3.06%
EPS Growth	-22.8
EPS Growth Q	25
EPS Growth Qo Q	318.4
EPS Growth3 Y	4.36
EPS Growth5 Y	-10.81
FCF Growth	-18.18%
OCF Growth	-3.4%
Revenue Growth	6.45x
Revenue Growth Q	22.31x
Revenue Growth Qo Q	28.01x
Revenue Growth3 Y	20.21x
Revenue Growth5 Y	8.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 66.6M
Debt	INR 744.8M
Debt EBITDA	INR 2.73
Debt Equity	INR 0.65
Debt FCF	INR 5.46
Equity	INR 1.1B
Interest Coverage	3.39
Net Cash	INR -678.2M
Net Cash By Market Cap	INR -24.49
Net Debt EBITDA	INR 2.49
Net Debt Equity	INR 0.6
Net Debt FCF	INR 4.97
Tangible Book Value	INR 696.3M
Tangible Book Value Per Share	INR 19.83
WACC	7.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.45%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	4
Dividend Yield	0.32%
Ex Div Date	2026-06-23
Last Dividend	INR 0.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	66.72%
200-day SMA	98.57
3Y total return	9.46%
50-day SMA	124.8
50-day SMA vs 200-day SMA	50over200
All Time High	235.8
All Time High Change	-34.27%
All Time High Date	2022-12-05
All Time Low	68.95
All Time Low Change	124.8%
All Time Low Date	2026-03-17
ATR	7.26
Beta	0.67
Beta1y	0.65
Beta2y	0.17
Ch YTD	72.99
High	163
High52	165
High52 Date	2026-09-07
High52ch	-6.06%
Low	155
Low52	68.95
Low52 Date	2026-03-17
Low52ch	124.8%
Ma50ch	24.18%
Price vs 200-day SMA	57.25%
RSI	66.19
RSI Monthly	63.87
RSI Weekly	81.42
Sharpe ratio	1.6x
Sharpe Ratio3y	0.22x
Sortino ratio	2.81
Sortino Ratio3y	0.49
Total Return	-11.13%
Tr YTD	72.99
Tr1m	36.81%
Tr1w	-3.91%
Tr3m	67.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,700,160%
Net Borrowing	-24,737,000
Shares Insiders	73.67%
Shares Out	17,850,000
Shares Qo Q	-49.31%
Shares Yo Y	11.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	46,801.15x
Bv Per Share	29.67
CAPEX	INR -57.9M
Ch1m	36.81
Ch1w	-3.91
Ch1y	65.95
Ch3m	67.57
Ch3y	6.9
Ch6m	86.64
Change	-4.24%
Change From Open	-4.9
Close	161.9
Days Gap	0.69
Depreciation Amortization	41,127,095
Dollar Volume	10,230
Earnings Date	2026-08-14
EBIT	INR 231.8M
EBITDA	INR 272.9M
EPS	INR 5.46
F Score	4
FCF	INR 136.5M
FCF EV Yield	3.85x
FCF Per Share	INR 7.65
Financing CF	11,133,000
Fiscal Year End	March
Founded	1,994
Graham Number	60.36284
Graham Upside	-61.06
Income Tax	INR 47.9M
Investing CF	-204,190,000
Is Primary Listing	1
Last Earnings Date	2026-08-14
Last Report Date	2026-06-30
Lynch Fair Value	INR 27.29
Lynch Upside	-82.39
Ma150	99.76
Ma150ch	55.37%
Ma20	147.5
Ma20ch	5.09%
Net CF	1,309,000
Next Earnings Date	2026-11-13
Open	163
P FCF Ratio	20.29
P OCF Ratio	14.25
Payment Date	2026-10-30
Position In Range	0
Price Date	2026-09-08
Price EBITDA	INR 10.15
Ptbv Ratio	3.98
Relative Volume	0x
Revenue	1,832,480,000x
Tax By Revenue	2.61x
Tax Rate	27.35%
Tr6m	86.64%
Volume	66

NSE/QMSMEDI (NSE/QMSMEDI)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/QMSMEDI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/QMSMEDI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/QMSMEDI

Frequently asked questions